NCT03949985View on ClinicalTrials.gov

Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives

CompletedOBSERVATIONAL

Enrollment

103

Participants

Timeline

Start Date

October 8, 2018

Primary Completion Date

September 14, 2020

Study Completion Date

September 14, 2020

Conditions

Venous ThromboembolismContraception

Interventions

OTHER

Tests of biological hemostatic profile associated with contraceptives

Tests of biological hemostatic profile associated with contraceptives will be done before and after having stopped an estrogenic contraceptive (group 1) and during the non-use of an estrogenic contraceptive (group 2)

Trial Locations (1)

1205

Geneva University Hospitals, Geneva

All Listed Sponsors

lead

University Hospital, Geneva

OTHER

NCT03949985 - Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives | Biotech Hunter | Biotech Hunter